AFLURIA TETRA
AFLURIA TETRA
Approved
DIN Number
02473313
Drug Class
Human
Market Date
Sep 23, 2020
Company
HC
SEQIRUS PTY LTD
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02473313
AIG Number0455410003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BB02 INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (4)
HAEMAGGLUTININ-STRAIN A (H1N1)Active
Strength: 15 MCG / 0.5 ML
Monograph: HAEMAGGLUTININ-STRAIN A (H1N1)
HAEMAGGLUTININ-STRAIN A (H3N2)Active
Strength: 15 MCG / 0.5 ML
Monograph: HAEMAGGLUTININ-STRAIN A (H3N2)
HAEMAGGLUTININ-STRAIN B (VICTORIA)Active
Strength: 15 MCG / 0.5 ML
Monograph: HAEMAGGLUTININ-STRAIN B (VICTORIA)
HAEMAGGLUTININ-STRAIN B (YAMAGATA)Active
Strength: 15 MCG / 0.5 ML
Monograph: HAEMAGGLUTININ-STRAIN B (YAMAGATA)